Sep 13, 2023 / 01:10PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
I'm Derik De Bruin, the Senior Life Sciences and Diagnostics Tools Analyst for Bank of America. Welcome to our 2023 Global Healthcare Conference, coming to you live from [London]. Our next company up today is QIAGEN. And with us from QIAGEN, we have Roland Sackers, CFO and Phoebe Loh from IR. Thank you for being here today. I appreciate you making the trip.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchSo do you want to -- I guess, I don't know the -- there's a lot to do, right? I think -- so coming out of 2Q earnings, the macro environment for life sciences is probably more uncertain than it has been in a long time, I would say. So let's do a world win tour of what QIAGEN is seeing, then we'll just go through this and pop it off and we'll hit down some of the specific product lines, and then I'll open up for questions later. So I've been marketing in the last couple of days in London, and #1 question in everyone's mind is China.
Trustpilot
